Under construction – not a live service
Sign in
Not yet recruitingPhase 2

DOXYCYCLINE PENETRATION INTO BONE AND JOINT.

Key facts

Who runs it
Centre Hospitalier Universitaire De Caen Normandie
Where
France1 site in 1 countryChoose a country to see its sites
Status
Not yet recruiting
Phase
Phase 2
People taking part
30 people, planned
Started
1 Jun 2026
Expected to end
1 Jun 2027
Type of study
Interventional
Record updated
20 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Age between 18 and 80 years old
  • Scheduled for elective surgery for hip replacement due to coxarthrosis
  • Signed informed consent
  • Patients eligible for French social insurance; Participants able to fully understand the study and who accept its requirements and constraints

Who cannot take part

  • Patient with a contraindication to surgical procedure
  • Patient who has received antibiotics within one month prior to the procedure
  • Patients with contraindications to doxycycline ( hypersensitivity to the active substance or to any of the excipients (particularly as generic formulations are authorized in the study and excipients may therefore differ), hypersensitivity to tetracycline-class antibiotics, co-administration of retinoids, or vitamin A supplementation exceeding 10,000 IU/day, due to the risk of intracranial hypertension and intestinal obstruction)
  • history of osteoarticular infection related to hip prosthesis surgery
  • Patient with an infection at the time of surgical management
  • malabsorption syndrome or conditions likely to impair antibiotic absorption (sleevs, colectomy, gastrointestinal antacids (magnesium, aluminum, or calcium salts, oxides, or hydroxides) and oral iron salts……)
  • Malnutrition patient (BMI < 21 kg/m2) or with serum albumin < 30g/L
  • Kidney failure with GFR < 60 mL/min/1,73m2
  • Women of childbearing age without effective contraception : childbearing age means non menopausal women. Effective contraception includes taking a contraceptive pill or using an Intra Uterine Device
  • Patient who did not take Doxycycline as planned in the protocol
  • Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators
  • Patients unable to take oral doxycycline
  • Pregnant or breastfeeding women
  • Patients under guardianship, curatorship, legal protection or conservatorship

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this study is to provide robust data on bone penetration of the doxycycline in non-infected patient. The primary objective is to determine the penetration of doxycycline in cancellous bone.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).
Record updated
20 July 2026